Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cerep down on lowered guidance

Cerep (NM:Cerep) was off EUR 1.76 (19%) to EUR 7.60 on

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE